Last update 01 Nov 2024
3D Medicines (Beijing) Co., Ltd.
Startups
|
Private Company|
2014|
Beijing Shi, China
| 50-100
Last update 01 Nov 2024
Overview
Basic Info
Introduction 3D Medicines Inc. is an innovative pharmaceutical company at the commercialization stage, focusing on the field of cancer treatment. It develops anti-cancer drugs in response to the trend of chronic cancer treatment. It has experience in drug discovery, preclinical research, clinical development, registration for listing and commercialization. Several indications have been recognized as orphan drugs by the FDA and NMPA or given priority for review. |
Tags
Neoplasms
Other Diseases
Congenital Disorders
Small molecule drug
Nanobody
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
A Randomized, Open-Label, Multicenter Phase 2 Study of Envafolimab in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin as the First-line Treatment in Patients With Locally Advanced or Metastatic Biliary Tract Cancers
An Open-label, Single Arm, Multicenter Phase 2 Study to Evaluate the Efficacy and Safety of 3D185 Monotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma With FGFR2 Gene Alterations
恩沃利单抗联合含铂双药化疗对比安慰剂联合含铂双药化疗用于可切除III期非小细胞肺癌患者新辅助/辅助治疗的随机、对照、双盲、多中心III期临床研究
[Translation] A randomized, controlled, double-blind, multicenter phase III clinical study of Envolizumab combined with platinum-based double-drug chemotherapy versus placebo combined with platinum-based double-drug chemotherapy for neoadjuvant/adjuvant treatment of patients with resectable stage III non-small cell lung cancer
100 Clinical Results associated with 3D Medicines (Beijing) Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with 3D Medicines (Beijing) Co., Ltd.
Login to view more data
100 Translational Medicine associated with 3D Medicines (Beijing) Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 24 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
1
Phase 2 Clinical
Approved
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free